European ADRs Move Higher in Wednesday Trading

Shutterstock photo

American depositary receipts of European stocks were trading 0.34% higher at 139.30 on the Bank of New York Mellon Europe ADR Index on Wednesday.

In continental Europe, the gainers were led by genome engineering firm Cellectis ( CLLS ), and pharmaceutical company Oasmia Pharmaceutical ( OASM ), which rose 11.8% and 6.4% respectively. They were followed by biotech firm Argenx ( ARGX ), and ASML ( ASML ), a manufacturer of chip-making equipment, which were up 5.6% and 1.7%.

The decliners in continental Europe were led by geophysical equipment company CGG ( CGG ), and telecommunications operator Telecom Italia (TI), which fell 4.4% and 2% respectively. They were followed by biotech company Zealand Pharma (ZEAL), and kidney dialysis company Fresenius Medical Care (FMS), which lost 1.8% and 1.6%.

In the UK and Ireland, the gainers were led by insurance firm Prudential (PUK), and Verona Pharma (VRNA), which climbed 6.8% and 2.7% respectively. Materials provider CRH (CRH), and biopharmaceutical company Adaptimmune Therapeutics (ADAP), rose 1.2% and 2.9% respectively.

The decliners in the UK and Ireland were led by biopharmaceutical company Amarin (AMRN), and gene therapy company Nightstar (NITE), which fell 2.9% and 1.2% respectively. They were followed by pharmaceutical company Avadel (AVDL), and telecommunications provider, BT Group (BT), which dropped 1.4% and 1%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Stocks
Referenced Symbols: CLLS , OASM , ARGX , ASML ,

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities

Research Brokers before you trade

Want to trade FX?